Technology : Overview

Liquidia's proprietary PRINT™ (Pattern Replication In Non-wetting Templates) technology is a novel nanotechnology platform that enables the design, development, and manufacture of precisely engineered nanoparticles and nano-patterned films for a wide range of commercial applications.

Liquidia is currently focused on applications within the Life and Materials Science sectors, with several products in the pipeline and additional products that are expected to reach the market in 2008. Within Life Sciences, Liquidia is developing Engineered Drug Therapies™ for targeted and effective delivery of therapeutics. Current programs focus on delivery of nucleic acids, and targeted oncology therapeutics. In Materials Science, Liquidia is developing nano-engineered films and membranes for precise light management in display and photovoltaic applications.

We invite you to learn more about the PRINT™ platform or explore our development and commercialization efforts in the following areas of focus: